November 5, 2012Transplant Studiesadmin -A Study provides further efficacy and safety data for BARACLUDE® in this special patient population-PARIS, Nov. 5, 2012 /PRNewswire/ Bristol-Myers Squibb announced today that the European Commission (EC) has approved a BARACLUDE® …
